Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “monoclonal”

203 pharma patents match "monoclonal" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 203
Index total 30,257
Page 3 / 9

Quick answer

This filtered view shows 203 pharmaceutical patents matching "monoclonal" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

203 results for “monoclonal” · 30,257 patents in full index Clear search

  1. US 10738112

    Anti-human interleukin-17A monoclonal antibody

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  2. US 10729781

    LGR4 specific monoclonal antibodies and methods of their use

    The Board of Regents of the University of Texas System · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  3. US 10711068

    Anti-CD133 monoclonal antibodies and related compositions and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  4. US 10689443

    Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  5. US 10640571

    Human monoclonal antibodies specific for glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 5, 2020 · Expires Apr 30, 2040

    granted

  6. US 10611827

    Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted

  7. US 10611851

    Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

    The Regents of the University of California · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted

  8. US 10604565

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Julius-Maximilians-Universitat Wurzburg · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

  9. US 10588982

    Site-specific covalent chemical ligation to monoclonal and polyclonal immunoglobulin

    The Regents of the University of California · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted

  10. US 10584161

    Monoclonal antibodies specific for heartland virus and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  11. US 10519222

    Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  12. US 10494435

    Human monoclonal antibodies specific for CD22

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  13. US 10479839

    Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

    The Regents of the University of California · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted

  14. US 10450371

    Monoclonal antibody and antigens for diagnosing and treating lung disease and injury

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  15. US 10444237

    Anti-pancreatic cancer monoclonal antibody and use thereof

    NANJING MARKERLINE BIOMEDICAL TECHNOLOGY CO., LTD. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  16. US 10428159

    Blocking monoclonal antibodies to AGR2 and its receptor C4.4A

    The Board of Regents of the University of Texas System · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted

  17. US 10421802

    Human monoclonal antibodies against the middle east respiratory syndrome coronavirus (MERS-CoV) and engineered bispecific fusions with inhibitory peptides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

  18. US 10413620

    Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  19. US 10400045

    Internalizing human monoclonal antibodies targeting prostate and other cancer cells

    The Regents of the University of California · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  20. US 10364295

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  21. US 10358501

    HER3 specific monoclonal antibodies for diagnostic and therapeutic use

    The Board of Regents of the University of Texas System · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

  22. US 10227395

    Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  23. IL 240179

    Use of a monoclonal, chimeric, human antibody that binds il-5r in the manufacture of a medicament for reducing the numbers of blood basophils in a human subject

    BIOWA INC [US] · Granted Dec 31, 2018 · Expires Dec 26, 2038

    granted

  24. US 10053503

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.